|
EEA1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.25379999999154E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.66179999999883E-05 |
| Normal-vs-Stage2 |
5.917700E-03 |
| Normal-vs-Stage3 |
4.16690000000219E-05 |
| Normal-vs-Stage4 |
2.39300000000053E-05 |
| Stage1-vs-Stage2 |
5.502200E-01 |
| Stage1-vs-Stage3 |
5.632200E-01 |
| Stage1-vs-Stage4 |
2.736000E-01 |
| Stage2-vs-Stage3 |
3.490200E-01 |
| Stage2-vs-Stage4 |
1.626560E-01 |
| Stage3-vs-Stage4 |
5.498600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.94056999999193E-05 |
| Normal-vs-AfricanAmerican |
3.366000E-02 |
| Normal-vs-Asian |
4.12859999999737E-05 |
| Caucasian-vs-AfricanAmerican |
4.905000E-01 |
| Caucasian-vs-Asian |
3.761400E-01 |
| AfricanAmerican-vs-Asian |
2.172000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.54669999988755E-07 |
| Normal-vs-Female |
4.46760000000213E-05 |
| Male-vs-Female |
1.747620E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.575900E-04 |
| Normal-vs-Age(41-60Yrs) |
4.83480000001979E-06 |
| Normal-vs-Age(61-80Yrs) |
1.632360E-04 |
| Normal-vs-Age(81-100Yrs) |
2.065600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.998000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.181400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.049600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.004400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.491400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.993400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.924800E-01 |
| Classical-VS-Follicular |
8.327400E-01 |
| Classical-VS-Other |
1.642180E-01 |
| Classical-VS-Normal |
3.60609999999761E-05 |
| Tall-VS-Follicular |
7.697800E-01 |
| Tall-VS-Other |
3.448800E-01 |
| Tall-VS-Normal |
3.302400E-03 |
| Follicular-VS-Other |
2.841000E-01 |
| Follicular-VS-Normal |
1.200090E-03 |
| Other-VS-Normal |
5.737000E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.08550000011665E-07 |
| Normal-vs-N1 |
3.8266000000009E-05 |
| N0-vs-N1 |
5.961200E-01 |
|
|
